Ushiyama S et al. |
RS-5186, a novel thromboxane synthetase inhibitor with a potent and extended duration of action. |
1988 |
Thromb. Res. |
pmid:3175990
|
Rogasi PG et al. |
Radioimmunoassay of thromboxane B2 in plasma: methodological modifications. |
1988 |
Thromb. Res. |
pmid:3175991
|
Schorer AE |
Discordant effects on eicosanoids and fibrin degradation products in two murine models of antiphospholipid antibody. |
1997 |
Thromb. Res. |
pmid:9062953
|
Kosaki G et al. |
The mechanism of the inhibitory effect of protease inhibitors on platelet aggregation and cellular synthesis of prostaglandins. I. The effect on the release of arachidonic acid from phospholipids. |
1980 Dec 1-15 |
Thromb. Res. |
pmid:6785893
|
Butler KD et al. |
Prolongation of platelet survival in hypercholesterolaemic rabbits by CGS 12970 (3-methyl-2-(3-pyridyl)-1 indoleoctanoic acid) and dazoxiben. |
1987 |
Thromb. Res. |
pmid:3109067
|
Anfossi G et al. |
Studies on in vitro effect of picotamide on human platelet aggregation in platelet-rich plasma and whole blood. |
1995 |
Thromb. Res. |
pmid:7778055
|
Watanabe T et al. |
Enhanced platelet sensitivity to prostacyclin in patients in an active stage of Takayasu arteritis. |
2001 |
Thromb. Res. |
pmid:11672751
|
Carroll RC et al. |
Post interventional cardiology urinary thromboxane correlates with PlateletMapping detected aspirin resistance. |
2010 |
Thromb. Res. |
pmid:19962724
|
Lee GY et al. |
Antiplatelet activity of BRX-018, (6aS,cis)-malonic acid 3-acetoxy-6a9-bis-(2-methoxycarbonyl-acetoxy)-6,6a,7,11b-tetrahydro-indeno[2,1-c]chromen-10-yl ester methylester. |
2005 |
Thromb. Res. |
pmid:15668191
|
Ziegler BK et al. |
Incomplete thromboxane inhibition with 100 mg of intravenous acetylsalicylic acid in patients with acute ST elevation myocardial infarction: a placebo-controlled pilot trial. |
2001 |
Thromb. Res. |
pmid:11672759
|
Ersöz G et al. |
The effect of submaximal exercise on platelet aggregation during late follicular and midluteal phases in women. |
2002 |
Thromb. Res. |
pmid:12590951
|
Mikashima H and Muramoto Y |
Protective effect of Y-20811, a long-lasting thromboxane synthetase inhibitor, on endotoxin shock in rabbits. |
1990 |
Thromb. Res. |
pmid:2326771
|
Agren JJ et al. |
Dose responses in platelet fatty acid composition, aggregation and prostanoid metabolism during moderate freshwater fish diet. |
1990 |
Thromb. Res. |
pmid:2326774
|
Kawamura M et al. |
Evaluation of plasma 11-dehydro-thromboxane B2 as an indicator for thromboxane A2 synthesis in vivo in laboratory animals. |
1995 |
Thromb. Res. |
pmid:7778061
|
Winter M et al. |
Synthesis of thromboxane B2 in uraemia and the effects of dialysis. |
1983 |
Thromb. Res. |
pmid:6868024
|
Ersöz G et al. |
Effect of sodium selenite treatment on platelet aggregation of streptozotocin-induced diabetic rats. |
2003 |
Thromb. Res. |
pmid:14698654
|
Addonizio VP et al. |
Inhibition of human platelet function by verapamil. |
1982 |
Thromb. Res. |
pmid:7164035
|
Vargaftig BB et al. |
Adrenaline and PAF-acether synergize to trigger cyclooxygenase-independent activation of plasma-free human platelets. |
1982 |
Thromb. Res. |
pmid:7164036
|
Grauso F et al. |
Effects of iloprost (ZK 36374), a prostacyclin derivative, on platelet function after ischaemic exercise in patients with stable angina pectoris. |
1987 |
Thromb. Res. |
pmid:2447664
|
Vlodavsky I et al. |
Platelet interaction with the extracellular matrix produced by cultured endothelial cells: a model to study the thrombogenicity of isolated subendothelial basal lamina. |
1982 |
Thromb. Res. |
pmid:7179215
|
Udvardy M et al. |
Plasma thromboxane and prostacyclin metabolite ratio in atherosclerosis and diabetes mellitus. |
1987 |
Thromb. Res. |
pmid:3116717
|
Cholette JM et al. |
Aspirin resistance following pediatric cardiac surgery. |
2010 |
Thromb. Res. |
pmid:20550971
|
Umemura K et al. |
Effect of dietary docosahexaenoic acid in the rat middle cerebral artery thrombosis model. |
1995 |
Thromb. Res. |
pmid:7660354
|
GarcÃa Frade LJ et al. |
Diabetes mellitus as a hypercoagulable state: its relationship with fibrin fragments and vascular damage. |
1987 |
Thromb. Res. |
pmid:3118498
|
Chou TC and Li CY |
Inhibitory mechanisms of dantrolene on platelet aggregation. |
1999 |
Thromb. Res. |
pmid:10593433
|
Carter AJ et al. |
Human pulmonary vessels obtained from necropsy produce less prostacyclin and thromboxane than fresh vessels obtained from operations. |
1984 |
Thromb. Res. |
pmid:6547546
|
Rousson D et al. |
Acute myocardial infarction: measurement of arachidonate end-products in whole blood as an index of platelet cyclo-oxygenase activity in vivo. |
1987 |
Thromb. Res. |
pmid:3122356
|
Ditter H et al. |
Effects of prostacyclin during cardiopulmonary bypass in men on plasma levels of beta-thromboglobulin, platelet factor 4, thromboxane B2, 6-keto-prostaglandin F1 alpha and heparin. |
1983 |
Thromb. Res. |
pmid:6197766
|
Navran SS et al. |
Human platelet activation by bacterial phospholipase C is mediated by phosphatidylinositol hydrolysis but not generation of phosphatidic acid: inhibition by a selective inhibitor of phospholipase C. |
1984 |
Thromb. Res. |
pmid:6372157
|
Shorr RI et al. |
In vitro effects of acetaminophen and its analogues on human platelet aggregation and thromboxane B2 synthesis. |
1985 |
Thromb. Res. |
pmid:3923647
|
Rostagno C et al. |
In vitro effects of two novel calcium antagonists (nitrendipine and nisoldipine) on intraplatelet calcium redistribution, platelet aggregation and thromboxane A2 formation. Comparison with diltiazem, nifedipine and verapamil. |
1991 |
Thromb. Res. |
pmid:1754998
|
Kankuri E et al. |
Effects of phenacetin and its metabolite p-phenetidine on COX-1 and COX-2 activities and expression in vitro. |
2003 |
Thromb. Res. |
pmid:14592552
|
Toivanen J et al. |
Differential inhibition of platelet thromboxane and lung prostacyclin production by sulphinpyrazone, acetylsalicylic acid and indomethacin by human tissues in vitro. |
1985 |
Thromb. Res. |
pmid:3920778
|
Stegmeier K et al. |
The pharmacological profile of the thromboxane A2 antagonist BM 13.177. A new anti-platelet and anti-thrombotic drug. |
1984 |
Thromb. Res. |
pmid:6385334
|
Mercer JB et al. |
The effect of short-term cold exposure on risk factors for cardiovascular disease. |
1999 |
Thromb. Res. |
pmid:10418798
|
Perneby C et al. |
Prothrombotic responses to exercise are little influenced by clopidogrel treatment. |
2004 |
Thromb. Res. |
pmid:15381386
|
Hall ER et al. |
The reduction of platelet thrombi on damaged vessel wall by a thromboxane synthetase inhibitor in rabbits. |
1982 |
Thromb. Res. |
pmid:6891109
|
Lukasik M et al. |
Aspirin treatment influences platelet-related inflammatory biomarkers in healthy individuals but not in acute stroke patients. |
2011 |
Thromb. Res. |
pmid:21788065
|
Gerrard JM et al. |
Studies in patients with bleeding disorders show that platelet-vessel interaction is important for thromboxane formation in bleeding time wounds. |
1990 |
Thromb. Res. |
pmid:2278038
|
Catella F and FitzGerald GA |
Paired analysis of urinary thromboxane B2 metabolites in humans. |
1987 |
Thromb. Res. |
pmid:3686481
|
Vericel E et al. |
Platelets and aging. I--Aggregation, arachidonate metabolism and antioxidant status. |
1988 |
Thromb. Res. |
pmid:3129819
|
Wang JP et al. |
Antiplatelet effect of capsaicin. |
1984 |
Thromb. Res. |
pmid:6528310
|
Cattaneo M et al. |
In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production. |
1991 |
Thromb. Res. |
pmid:1926062
|
Koh H et al. |
A radioimmunoassay of thromboxane B2 with thromboxane B2-125I-tyramide and its application to the study on the thromboxane B2 formation during platelet aggregation. |
1980 Feb 1-15 |
Thromb. Res. |
pmid:7368170
|
Tindall H et al. |
Thrombin generation precedes platelet activation in native blood taken from the hand during multiple blood sampling following cold challenge. |
1987 |
Thromb. Res. |
pmid:3617016
|
Kohda N et al. |
Effect of cilostazol, a phosphodiesterase III inhibitor, on experimental thrombosis in the porcine carotid artery. |
1999 |
Thromb. Res. |
pmid:10593428
|
Deckmyn H et al. |
Prostacyclin production by whole blood from children: impairment in the hemolytic uremic syndrome and excessive formation in chronic renal failure. |
1983 |
Thromb. Res. |
pmid:6344317
|
Mannucci L et al. |
Indobufen is a potent inhibitor of whole blood aggregation in patients with a high atherosclerotic risk. |
1987 |
Thromb. Res. |
pmid:3445229
|
Nosál' R et al. |
Chloroquine: a multipotent inhibitor of human platelets in vitro. |
2000 |
Thromb. Res. |
pmid:10828481
|
Winther K et al. |
Platelet function and fibrinolytic activity in cervical spinal cord injured patients. |
1992 |
Thromb. Res. |
pmid:1321515
|
Buchanan MR et al. |
The sex-related differences in aspirin pharmacokinetics in rabbits and man and its relationship to antiplatelet effects. |
1983 |
Thromb. Res. |
pmid:6221436
|
Randall MJ and Wilding RI |
Acute arterial thrombosis in rabbits: reduced platelet accumulation after treatment with thromboxane synthetase inhibitor dazoxiben hydrochloride, (UK-37, 248-01). |
1982 |
Thromb. Res. |
pmid:6897751
|
Di Minno G and Violi F |
Aspirin resistance and diabetic angiopathy: back to the future. |
2004 |
Thromb. Res. |
pmid:15115664
|
Vesterqvist O et al. |
Development of a GC-MS method for quantitation of 2,3-dinor-TxB2 and determinations of the daily urinary excretion rates in healthy humans. |
1984 |
Thromb. Res. |
pmid:6695361
|
Best LC et al. |
Mode of action of dipyridamole on human platelets. |
1979 |
Thromb. Res. |
pmid:229583
|
Tanoue K et al. |
A new variant of thrombasthenia with abnormally glycosylated GP IIb/IIIa. |
1987 |
Thromb. Res. |
pmid:3629560
|
Zijlstra FJ et al. |
Thrombotic thrombocytopenic purpura and plasma thromboxane B2 levels. |
1983 |
Thromb. Res. |
pmid:6684333
|
Altman R and Scazziota A |
Synergistic actions of paf-acether and sodium arachidonate in human platelet aggregation. 2. Unexpected results after aspirin intake. |
1986 |
Thromb. Res. |
pmid:3088757
|
Maderna P et al. |
Differential effects of oral administrations to human volunteers of acetylsalicylic acid, sodium salicylate and indomethacin on 12-hydroxyeicosatetraenoic acid formation by stimulated platelets. |
1988 |
Thromb. Res. |
pmid:3194896
|
Davì G et al. |
Inhibition of platelet function by ticlopidine in arteriosclerosis obliterans of the lower limbs. |
1985 |
Thromb. Res. |
pmid:2933846
|
|
Platelet function during long-term treatment with ketanserin of claudicating patients with peripheral atherosclerosis. A multi-center, double-blind, placebo-controlled trial. The PACK Trial Group. |
1989 |
Thromb. Res. |
pmid:2528841
|
Pattison A et al. |
The in vitro effect of amrinone on thromboxane B2 synthesis in human whole blood. |
1986 |
Thromb. Res. |
pmid:3755259
|
Maguire ED and Wallis RB |
In vivo redirection of prostaglandin endoperoxides into 6-keto PGF1 alpha formation by thromboxane synthetase inhibitors in the rat. |
1983 |
Thromb. Res. |
pmid:6689221
|
Hashimoto Y et al. |
Characteristics of protein kinase C-independent exocytosis in human platelets. |
1997 |
Thromb. Res. |
pmid:9336873
|
Yue TL et al. |
Pharmacological profile of G619, a new platelet aggregation inhibitor. |
1992 |
Thromb. Res. |
pmid:1412200
|
Di Minno MN et al. |
Genotype-independent in vivo oxidative stress following a methionine loading test: maximal platelet activation in subjects with early-onset thrombosis. |
2011 |
Thromb. Res. |
pmid:21669453
|
Ames PR et al. |
Aspirin insensitive thromboxane generation is associated with oxidative stress in type 2 diabetes mellitus. |
2012 |
Thromb. Res. |
pmid:22521214
|
Li C et al. |
Aspirin response variability after major orthopedic surgery. |
2012 |
Thromb. Res. |
pmid:22575418
|
Takasaki W et al. |
Enzyme immunoassay of human plasma 11-dehydrothromboxane B2. |
1991 |
Thromb. Res. |
pmid:1957275
|
Hofmann D et al. |
Evidence for sustained platelet activation in patients with early postinfarction angina. |
1993 |
Thromb. Res. |
pmid:8303651
|
Toft G et al. |
Intravenously and topically applied magnesium in the prevention of arterial thrombosis. |
2000 |
Thromb. Res. |
pmid:10904104
|
Korth R et al. |
Unsaturated platelet-activating factor: influence on aggregation, serotonin release and thromboxane synthesis of human thrombocytes. |
1986 |
Thromb. Res. |
pmid:3961742
|
Pinto S et al. |
No signs of increased thrombin generation in menopause. |
1990 |
Thromb. Res. |
pmid:2201101
|
Riess H et al. |
Thromboxane receptor blockade versus cyclooxigenase inhibition: antiplatelet effects in patients. |
1986 |
Thromb. Res. |
pmid:3012819
|
Pirich C et al. |
Effects of fish oil supplementation on platelet survival and ex vivo platelet function in hypercholesterolemic patients. |
1999 |
Thromb. Res. |
pmid:10588465
|
De Caterina R et al. |
Inhibition of platelet aggregation and thromboxane B2 production during aspirin treatment: dependence on the dose of the aggregating agent. |
1985 |
Thromb. Res. |
pmid:3975876
|
Altman R et al. |
Synergistic actions of PAF-acether and sodium arachidonate in human platelet aggregation. 1. Studies in normal human platelet rich plasma. |
1986 |
Thromb. Res. |
pmid:3014677
|
Worthington RE and Fuller GC |
Dibutyryl cyclic guanosine monophosphate elevates bovine endothelial cell thromboxane production without affecting prostacyclin metabolism. |
1984 |
Thromb. Res. |
pmid:6322377
|
Teng CM et al. |
Platelet aggregation induced by equinatoxin. |
1988 |
Thromb. Res. |
pmid:2906181
|
Selley ML et al. |
The effect of cholesterol oxidation products on human platelet aggregation. |
1996 |
Thromb. Res. |
pmid:8885139
|
Kritz H et al. |
Isradipine increases vascular prostaglandin I2-formation while the thromboxane B2-synthesis is diminished. |
1995 |
Thromb. Res. |
pmid:8610276
|
De Caterina R et al. |
Long-term maintenance of thromboxane inhibition by two different aspirin regimens in patients with unstable angina. |
1990 |
Thromb. Res. |
pmid:2126400
|
Kelton JG et al. |
Sex-related differences in the efficacy of acetylsalicylic acid (ASA) : the absorption of ASA and its effect on collagen-induced thromboxane B2 generation. |
1981 Oct 1-15 |
Thromb. Res. |
pmid:7330835
|
Yamaguchi A et al. |
Effect of cetiedil on platelet aggregation and thromboxane synthesis. |
1985 |
Thromb. Res. |
pmid:2986312
|
Wang JP et al. |
XC 386: a new antiplatelet agent. |
1984 |
Thromb. Res. |
pmid:6438827
|
Prosdocimi M et al. |
Inhibition by AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonyl methoxy coumarin) of platelet aggregation in dog stenosed coronary artery. |
1985 |
Thromb. Res. |
pmid:3840290
|
Carter AJ and Jones EW |
The effect of the degree of diabetic control on thromboxane synthesis in clotted whole blood. |
1986 |
Thromb. Res. |
pmid:3515613
|
Mogensen F et al. |
Effect of specific thromboxane-synthetase inhibition on thromboxane and prostaglandin synthesis in stable angina induced by exercise test. |
1985 |
Thromb. Res. |
pmid:4038824
|
Antonino MJ et al. |
Antiplatelet effects of aspirin with phytosterols: comparison with non-enteric coated aspirin alone. |
2010 |
Thromb. Res. |
pmid:19446864
|
Neiman J et al. |
Platelet responses to platelet-activating factor are inhibited in alcoholics undergoing alcohol withdrawal. |
1989 |
Thromb. Res. |
pmid:2617478
|
Neiman J et al. |
Platelet uptake of serotonin (5-HT) during ethanol withdrawal in male alcoholics. |
1987 |
Thromb. Res. |
pmid:2820078
|
Altman R et al. |
Why single daily dose of aspirin may not prevent platelet aggregation. |
1988 |
Thromb. Res. |
pmid:3140408
|
Simmet T and Weide I |
Thromboxane and cysteinyl-leukotriene formation are differentially activated in spontaneously clotting whole human blood in vitro. |
1991 |
Thromb. Res. |
pmid:1866709
|
Weigel G et al. |
Regulation of eicosanoid release in human umbilical endothelial cells. |
1991 |
Thromb. Res. |
pmid:1656543
|
Ko FN et al. |
Antiplatelet effects of protopine isolated from Corydalis tubers. |
1989 |
Thromb. Res. |
pmid:2559491
|
Swart SS et al. |
Functional significance of the platelet alpha2-adrenoceptor: studies in patients with myeloproliferative disorders. |
1984 |
Thromb. Res. |
pmid:6326344
|
Ito T et al. |
Role of activated platelets in endotoxin-induced DIC in rats. |
1990 |
Thromb. Res. |
pmid:2080492
|
Alessandrini P et al. |
Physiologic variables affecting thromboxane B2 production in human whole blood. |
1985 |
Thromb. Res. |
pmid:3983893
|
Lukaszyk A et al. |
Blood platelet function in canine acute pancreatitis with reference to treatment with Nafamostat mesilate (FUT-175). |
1992 |
Thromb. Res. |
pmid:1579898
|
Meyers KM et al. |
An evaluation of the arachidonate pathway of platelets from companion and food-producing animals, mink, and man. |
1980 |
Thromb. Res. |
pmid:7209869
|